In this research report Transparency Market Research analyzes the global high-potency active pharmaceutical ingredients market (HPAPI) along with market dynamics and present market condition. It also covers the market of high-potency active pharmaceutical ingredients types and application in different regions of the world namely, North America, Europe, Asia and RoW along with their sub segments. Moreover, the report provides detailed and in-depth analysis of the HPAPI market, with their estimated figures and forecast from 2012 to 2018, along with compound annual growth rate from 2012 to 2018.

The global high-potency active pharmaceutical ingredients market has shown favorable growth trend in the last few years and is expected to grow rapidly in the forecasted period. The demand of oncology products is further expected to drive the growth of this market. The high level of competition in this market is due to new entrants fragmenting the market. HPAPI market by type of synthesis has been covered in this report providing their estimates and forecast from 2012 to 2018. The drivers, restraints and opportunities have also been covered broadly in this report along with their impact analysis. These market dynamics will be highly helpful in taking corporate decisions related to the HPAPI market.

We have used secondary research for deriving our market numbers for each segment of the research report and further validated our analysis with C-level executives of major companies operating in the high-potency active pharmaceutical ingredients market through means of primary research to finally come up with our results. This report also provides company profiles of the major players in the HPAPI market. Our company profile provides company and financial overview, business, strategies adopted by the companies, SWOT analysis and their recent developments which can help in assessing the competition in the market. Some of the major companies included in this report are Pfizer, Roche, Novartis, GlaxoSmithKline Pharmaceuticals Ltd., BASF Se, Hospira Inc., Matrix Laboratories Limited, Covidein Plc and Astra Geneca International, among others.

In this research report Transparency Market Research analyzes the performance of high potency active pharmaceutical ingredients market in a global scenario. The research provides in-depth analysis of market sales, trend analysis by segments and demand by geography. The report covers all the major product types and application segments of the HPAPIs market and provides in-depth analysis, historical data and statistically refined forecast for the segments covered. The study presents a comprehensive assessment of the stakeholder strategies and winning imperatives for them by segmenting the global high potency active pharmaceutical ingredients market as below:

• Introduction   
• HPAPI Classification as per Safebridge Consultants   
• Overview: HPAPI Global Market  
• Manufacturing Capabilities   

• Handling requirements   
• Personnel considerations   
• Plant & equipment   
• Technology

• Synthetic HPAPI
• Biotech HPAPI

• Captive or In-house manufacturers
• Merchant or Third party manufacturers

• Innovative   
• Generic

• North America
• Europe
• Asia
• RoW

The in-depth research and high level analysis will allow high potency active pharmaceutical ingredients product manufacturers, lawmakers, large retailers, medical companies and research and development agencies to make informed decisions about high potency active pharmaceutical Ingredients product manufacturing, designing marketing, growth strategies and gaining competitive advantage.